Enovix (ENVX) CAO granted common stock as PRSU awards vest

Rhea-AI Filing Summary

Enovix Corp Chief Accounting Officer Kristina Truong reported acquiring common stock through the vesting of performance restricted stock units (PRSUs) after performance criteria were achieved on February 18, 2026. Awards covering 24,116 PRSUs and 11,162 PRSUs vested at a price of $0.00 per share.

The 24,116 vested PRSUs will be released in two equal installments on April 1, 2027 and April 1, 2028, and the 11,162 vested PRSUs will be released in two equal installments on April 8, 2027 and April 8, 2028. Each PRSU represents a contingent right to receive one share of Enovix common stock upon settlement.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Truong Kristina

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	24,116	$0.00	--
Grant/Award	Common Stock	11,162	$0.00	--

Holdings After Transaction: Common Stock — 214,405 shares (Direct)

Footnotes (1)

1. Represents the vesting of 24,116 performance restricted stock units ("PRSUs") upon the achievement of certain performance criteria on February 18, 2026, of which 50% will be released on April 1, 2027 and the remaining 50% will be released on April 1, 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. Includes 137,235 shares issuable upon the vesting and settlement of restricted stock units ("RSUs") granted to the Reporting Person, as well as the above referenced vested PRSUs and 2,489 vested PRSUs which will be released on March 2, 2027. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. Represents the vesting of 11,162 performance restricted stock units ("PRSUs") upon the achievement of certain performance criteria on February 18, 2026, of which 50% will be released on April 8, 2027 and the remaining 50% will be released on April 8, 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Truong Kristina

(Last) (First) (Middle)

3501 W WARREN AVENUE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		A		24,116(1)	A	$0	214,405(2)	D
Common Stock	02/18/2026		A		11,162(3)	A	$0	225,567(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the vesting of 24,116 performance restricted stock units ("PRSUs") upon the achievement of certain performance criteria on February 18, 2026, of which 50% will be released on April 1, 2027 and the remaining 50% will be released on April 1, 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

2. Includes 137,235 shares issuable upon the vesting and settlement of restricted stock units ("RSUs") granted to the Reporting Person, as well as the above referenced vested PRSUs and 2,489 vested PRSUs which will be released on March 2, 2027. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

3. Represents the vesting of 11,162 performance restricted stock units ("PRSUs") upon the achievement of certain performance criteria on February 18, 2026, of which 50% will be released on April 8, 2027 and the remaining 50% will be released on April 8, 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

Remarks:

	/s/ Arthi Chakravarthy, Attorney-in-Fact for Kristina Truong	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovix (ENVX) report for Kristina Truong?

Enovix reported that Chief Accounting Officer Kristina Truong acquired common stock through the vesting of performance restricted stock units. Two PRSU awards vested on February 18, 2026, reflecting equity-based compensation tied to achieving specified performance criteria rather than an open-market stock purchase.

How many Enovix (ENVX) shares vested for Kristina Truong in this Form 4?

Two PRSU tranches vested: one covering 24,116 units and another covering 11,162 units. Each performance restricted stock unit represents a contingent right to receive one share of Enovix common stock upon settlement, resulting in equity awards rather than cash compensation for the executive.

When will the vested Enovix (ENVX) PRSUs reported by Kristina Truong be released?

The 24,116 vested PRSUs will be released in two equal parts on April 1, 2027 and April 1, 2028. The 11,162 vested PRSUs will be released in two equal parts on April 8, 2027 and April 8, 2028, subject to the award terms.

What does each Enovix (ENVX) PRSU reported in this filing represent?

Each performance restricted stock unit reported represents a contingent right to receive one share of Enovix common stock upon settlement. The units vest only after specified performance criteria are achieved, then are released to the executive on future scheduled dates as outlined in the award terms.